ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER

WilliamH. Allum; MichaelT. Hallissey; K. Kelly; British Stomach Cancer Group

doi:10.1016/s0140-6736(89)91607-3

Keywords

MedicineCyclophosphamideVincristineAdjuvantGastrectomyMethotrexateSurgeryChemotherapyMitomycin CInternal medicineOncologyResection marginStage (stratigraphy)AdenocarcinomaMultivariate analysisCancerResection

Affiliated Institutions

Queen Elizabeth Hospital Birmingham GB

Related Publications

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

David Cunningham , William Allum , Sally Stenning +12 more

In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free ...

2006 New England Journal of Medicine 6200 citations

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study

John S. Macdonald , Thomas R. Fleming , Robert F. Peterson +10 more

1995 Annals of Surgical Oncology 123 citations

Prognostic relevance of systematic lymph node dissection in gastric carcinoma

J R Siewert , K. Böttcher , J. D. Roder +3 more

Abstract In a prospective multicentre study of 2394 patients with gastric carcinoma the prognostic relevance of systematic lymph node dissection was evaluated. Of 1654 patients ...

1993 British journal of surgery 453 citations

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters , A. Norman , David Cunningham +12 more

We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF re...

1999 British Journal of Cancer 278 citations

Preoperative Systemic Chemoimmunotherapy and Sequential Resection for Unresectable Hepatocellular Carcinoma

W. Y. Lau , Thomas Leung , Bo-san Lai +4 more

Combined modalities with systemic chemoimmunotherapy and surgical resection can achieve complete clinical remission and long-term control of disease in patients with unresectabl...

2001 Annals of Surgery 135 citations

Publication Info

Year: 1989
Type: article
Volume: 333
Issue: 8638
Pages: 571-574
Citations: 97
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    WilliamH. Allum, 
                                
                                    MichaelT. Hallissey, 
                                
                                    K. Kelly
                                
                                et al.
                            
                            (1989). 
                            ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER. 
                            The Lancet
                            , 333
                            (8638)
                            , 571-574.
                            https://doi.org/10.1016/s0140-6736(89)91607-3
                        

Identifiers

DOI: 10.1016/s0140-6736(89)91607-3